The review presents data of clinical and pharmacogenetic research by Russian and foreign authors conducted within the last three years on the effectiveness of anti-angiogenic treatment against wet age-related macular degeneration (AMD). Scientific results on the association between angiogenesis-related gene polymorphisms responsible for predisposition to AMD on the one hand and a positive response to anti-VEGF therapy on the other are presented. Particular attention is paid to the main regulator of angiogenesis – the VEGF-A gene.
CITATION STYLE
Moshetova, L. K., Sychev, D. A., Osmanova, E. R., & Turkina, K. I. (2017). Role of genetic markers in personalization of anti-angiogenic therapy in patients with exudative age-related macular degeneration. Vestnik Oftalmologii. Media Sphera Publishing Group. https://doi.org/10.17116/oftalma20171336120-125
Mendeley helps you to discover research relevant for your work.